Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28

Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.

MD

0.00

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE: MD) with a Hold and raises the price target from $23 to $28.